In recent years, there has been an explosion of discoveries related to the interplay between genetics, health, and disease. The availability of molecular biology techniques such as Next Generation Sequencing (NGS) has enabled us to decode the human genome and showcase the hidden secrets behind many genetic challenges. Pier 23 Labs harnesses the power of molecular genetics to deliver cutting-edge clinical research services. In this blog post, we will delve into the expertise of Pier 23 Labs’s team in NGS, and how it impacts health.
The NGS technology has transformed the way clinical research can be done. It offers quicker, accurate, and cost-effective analyses of molecular data. Pier 23 Labs is home to the latest and most innovative NGS tools, thus providing its clients with high-throughput sequencing, molecular barcoding, and bioinformatics processing. These molecular genetics techniques have helped improve the efficiency of clinical research by identifying novel genetic factors in disease pathology as well as advancing our understanding of various medical conditions.
Molecular Genetics Applications in Clinical Research
Our team at Pier 23 Labs has worked on various projects, including the identification of cancerous and infectious agents in patients using NGS techniques. The applications of molecular genetics in clinical research have unraveled new targets for therapeutic intervention. For instance, our team has been part of the recent discoveries of somatic mutations in cancerous tumors that have accompanied drug resistance and the development of therapeutic strategies for breast cancer and other malignancies.
Impact on Health
NGS technology is a crucial tool that helps understand the genetics behind diseases, enabling the identification of targeted therapeutic approaches. Our focus at Pier 23 Labs is to develop diagnostic tests that offer physicians the ability to tailor therapies for patients’ specific genetic risks and diseases. Our NGS-guided molecular diagnostics analyses have provided individualized medicine approaches for molecular cancer, neurological disease, and inherited disorders.
Conclusion:
Pier 23 Labs represents the application of the latest genomics tools and techniques to bring about precision medicine. Our mission at Pier 23 Labs is to leverage molecular genetics discoveries to lead the way in clinical research. We deliver high-throughput sequencing, molecular barcoding, and bioinformatics processing enabling the deeper understanding of disease pathology and the offering of precision genomic medicine for individual patients over a range of conditions. By leveraging our expertise in NGS, we partner with physicians, healthcare, and life sciences companies to drive research findings into the clinic, thereby translating genomic discoveries into practical clinical use.
